Friday, May 10, 2013
Argos Therapeutics Inc., of Durham, N.C., disclosed the publication of findings on its RNA amplification process. The study confirmed that the company's improved RNA amplification techniques enhance the quality of the resultant antigen-specific immune response.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.